Testing effectiveness (Phase 2)Ended earlyNCT05652907
What this trial is testing
Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)
Who this might be right for
Mast Cell Activation SyndromeMast Cell Activation Disorder Idiopathic
Quantum Biopharma 2